Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers

IMPORTANCE: Accurate risk prediction models using routinely measured biomarkers—eg, carbohydrate antigen 19-9 (CA19-9) and bilirubin serum levels—for pancreatic cancer could facilitate early detection of pancreatic cancer and prevent potentially unnecessary diagnostic tests for patients at low risk....

Descripción completa

Detalles Bibliográficos
Autores principales: Boyd, Lenka N. C., Ali, Mahsoem, Comandatore, Annalisa, Garajova, Ingrid, Kam, Laura, Puik, Jisce R., Fraga Rodrigues, Stephanie M., Meijer, Laura L., Le Large, Tessa Y. S., Besselink, Marc G., Morelli, Luca, Frampton, Adam, van Laarhoven, Hanneke W. M., Giovannetti, Elisa, Kazemier, Geert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463099/
https://www.ncbi.nlm.nih.gov/pubmed/37639271
http://dx.doi.org/10.1001/jamanetworkopen.2023.31197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463099/
https://www.ncbi.nlm.nih.gov/pubmed/37639271
http://dx.doi.org/10.1001/jamanetworkopen.2023.31197

Ejemplares similares